Dietger W. Niederwieser
Dietger W. Niederwieser publishes mostly in Hematology, Genetics and Immunology, on topics such as Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research and Chronic Myeloid Leukemia Treatments.
- World rank
- #292,866 of 7,710,434 ranked researchers
- Rank in Germany
- #14,661 of 364,343
- Works
- 983
- Citations
- 63k
- Citations per work
- 64.4
What does Dietger W. Niederwieser research?
Dietger W. Niederwieser's work is mostly in Medicine (64%), Immunology and Microbiology (8%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences62463.5%
- Medicine62463.5%
- Everything else21822.2%
- Life Sciences14114.3%
- 1Hematology40% of their works
- 2Genetics10% of their works
- 3Immunology8% of their works
- 4Oncology7% of their works
- 5Public Health, Environmental and Occupational Health7% of their works
- 6Molecular Biology6% of their works
Research topics
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- T-cell and B-cell Immunology
Which keywords describe Dietger W. Niederwieser's research?
The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Bone Marrow Niche, Graft-versus-Host Disease, Acute Myeloid Leukemia, AML, Minimal Residual Disease and BCR-ABL.
- Foxp3
- JAK2 Mutation
- Diagnosis Criteria
- Chronic Lymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Acute Myeloid Leukemia
- Graft-versus-Host Disease
- Prognostic Factors
- Hematopoietic Stem Cells
- Bone Marrow Niche
- AML
- Minimal Residual Disease
- Imatinib
- Childhood Cancer
- Genomic Aberrations
- International Myeloma Working Group
- Myelofibrosis
- TGF-ß
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Hematopoietic Stem Cells7272 topics
- Prognostic Factors6583 topics
- Bone Marrow Niche3851 topic
- Graft-versus-Host Disease3851 topic
- AML3421 topic
- Acute Myeloid Leukemia3421 topic
- Minimal Residual Disease2832 topics
- BCR-ABL2331 topic
- Imatinib2331 topic
- Acute Lymphoblastic Leukemia1711 topic
- Childhood Cancer1711 topic
- Chronic Lymphocytic Leukemia1451 topic
- Genomic Aberrations1451 topic
- Diagnosis Criteria1121 topic
- International Myeloma Working Group1121 topic
- JAK2 Mutation751 topic
- Myelofibrosis751 topic
- Foxp3631 topic
- TGF-ß631 topic
Where does Dietger W. Niederwieser work?
Dietger W. Niederwieser's main affiliation in the publication record is Leipzig University, Germany.
How many publications and citations does Dietger W. Niederwieser have?
OpenAlex counts 983 works and 63,315 citations for Dietger W. Niederwieser, an h-index of 105, ranking #292,866 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dietger W. Niederwieser. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.